evaluation of TAK-243 in SCLC products, thus the translational prospective of concentrating on UBA1 for SCLC is not known. The restricted cell line analyses also preclude biomarker interrogation. Herein, we leveraged a considerable panel of SCLC mobile traces and in vivoZetia includes the Energetic drug ezetimibe. It belongs to a class of drugs ref